Barnes Akathisia Rating Scale (BARS)

Similar documents
Modified Hachinski Ischemic Scale: NACC Version (MHIS-NACC) v.1.0

Brief Psychiatric Rating Scale-Anchored (BPRS-A)

Brief Psychiatric Rating Scale-Anchored (BPRS-A)

Epworth Sleepiness Scale (ESS)

Hospital Anxiety and Depression Scale (HADS)

Clinical Global Impression (CGI)

Disability Assessment for Dementia (DAD)

Michigan Neuropathy Screening Instrument (MNSI)

Neuropathic Pain Scale (NPS)

Hamilton Depression Rating Scale 17-Item (HAMD 17)

Columbia-Suicide Severity Rating Scale Baseline (C-SSRS BASELINE)

Columbia-Suicide Severity Rating Scale Baseline (C-SSRS BASELINE)

Columbia-Suicide Severity Rating Scale Baseline (C-SSRS BASELINE)

Short-Form McGill Pain Questionniare-2 (SHORT-FORM MPQ-2)

Timed Up and Go (TUG)

Pain Relief (PR) Notes to Readers

Unified Parkinson's Disease Rating Scale UPDRS

Unified Parkinson's Disease Rating Scale UPDRS

Let s Create Standard Value Level Metadata

PharmaSUG Paper DS12

CDISC BrCa TAUG & Oncology Information Session

Alzheimer s Disease-specific Therapeutic Area Supplement to the Study Data Tabulation Model User Guide

Intervention ML: Mapping of Meal data. Rahul Loharkar, inventiv Health Clinical, Pune, India Sandeep Sawant, inventiv Health Clinical, Mumbai, India

Project Charter. Template v2 June 3, February 25, Name of Project: Prostate Cancer (PrCa) Therapeutic Area Data Standards

A Rating Scale for Drug-Induced Akathisia

Jerry Salyers, Accenture Accelerated R&D Services Fred Wood, Accenture Accelerated R&D Services. PhUSE 2017 Edinburgh, Scotland Paper #DS05

How to manage changes to CDISC standards at Novo Nordisk. PhUSE EU Connect 2018 Sune Dandanell and Mikkel Traun

Therapeutic Area User Guide Cardiovascular V1.0 Public Review Webinar April 3, 2014

CFAST Asthma Project. Rhonda Facile. CDISC International Interchange Session 4B: Therapeutic Area Standards in Action November 6, 2013

CDISC - Mapping New Pathways for Novartis. Darren Weston, Project Leader Pat Majcher, Senior Principal Programmer

Examples: Tables. Descriptive stats with ANOVA, ANCOVA, and t test p values Frequency and percent Correlation coefficients

Design and Construct Efficacy Analysis Datasets in Late Phase Oncology Studies

IAASB Main Agenda (March 2005) Page Agenda Item. DRAFT EXPLANATORY MEMORANDUM ISA 701 and ISA 702 Exposure Drafts February 2005

PharmaSUG Paper DS04

ADaM Considerations and Content in the TA User Guides. Susan J Kenny, PhD Maximum Likelihood, Inc.

The Standard for the Exchange of Nonclinical Data (SEND): History, Basics, and Comparisons with Clinical Data

PharmaSUG 2018 Paper AD-02

Quality ID #168 (NQF 0115): Coronary Artery Bypass Graft (CABG): Surgical Re-Exploration National Quality Strategy Domain: Effective Clinical Care

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

SDTMIG v3.3 Batch 2 Upcoming Public Review. Presented by Fred Wood

DENOMINATOR: All patients undergoing anterior or apical pelvic organ prolapse (POP) surgery

Quality ID #178: Rheumatoid Arthritis (RA): Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care

Measure #412: Documentation of Signed Opioid Treatment Agreement National Quality Strategy Domain: Effective Clinical Care

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

Request for Proposals

Quality ID #397: Melanoma Reporting National Quality Strategy Domain: Communication and Care Coordination

Measure #355: Unplanned Reoperation within the 30 Day Postoperative Period National Quality Strategy Domain: Patient Safety

Leveraging Standards for Effective Visualization of Early Efficacy in Clinical Trial Oncology Studies

Quality ID #1 (NQF 0059): Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) National Quality Strategy Domain: Effective Clinical Care

Quality ID #278: Sleep Apnea: Positive Airway Pressure Therapy Prescribed National Quality Strategy Domain: Effective Clinical Care

CDISC Public Webinar- Post Traumatic Stress Disorder Therapeutic Area User Guide

PARKINSON S DISEASE MEDICAL ASSESSMENT FORM FOR SOCIAL SECURITY DISABILITY APPLICATION

Quality ID #249 (NQF 1854): Barrett s Esophagus National Quality Strategy Domain: Effective Clinical Care

Quality ID #117 (NQF 0055): Diabetes: Eye Exam National Quality Strategy Domain: Effective Clinical Care

Measure #178: Rheumatoid Arthritis (RA): Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care

DESCRIPTION: Percentage of final reports for screening mammograms that are classified as probably benign

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Efficiency

CDISC Controlled Terminology. Presented by Chris Gemma and Erin Muhlbradt, Ph.D.

DENOMINATOR: All patients undergoing anterior or apical pelvic organ prolapse (POP) surgery

REX REX Clinical Assessment Guide

DENOMINATOR: All patient visits for patients aged 21 years and older with a diagnosis of OA

DENOMINATOR: All patients undergoing anterior or apical pelvic organ prolapse (POP) surgery

DESCRIPTION: Percentage of final reports for screening mammograms that are classified as probably benign

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Outcome High Priority

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

Quality ID#164 (NQF 0129): Coronary Artery Bypass Graft (CABG): Prolonged Intubation National Quality Strategy Domain: Effective Clincial Care

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Clinical Review Report (Sample)

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process

Disclaimer. The following report contains a description of the request, request specifications, and results from the modular program run(s).

Residual Functional Capacity Questionnaire PARKINSON S DISEASE

OPNAVINST G 30 Dec 05

Measure #110 (NQF 0041): Preventive Care and Screening: Influenza Immunization National Quality Strategy Domain: Community/Population Health

Ankle Sprain. Information for patients. This booklet provides information for patients with ankle sprain. Physiotherapy

2019 CMS Web Interface

Measure #412: Documentation of Signed Opioid Treatment Agreement National Quality Strategy Domain: Effective Clinical Care

Adult ADHD-RS-IV* with Adult Prompts

DENOMINATOR: All patients aged 18 years and older with a diagnosis of chronic hepatitis C cirrhosis

Measure #397: Melanoma Reporting National Quality Strategy Domain: Communication and Care Coordination

Quality ID #154 (NQF: 0101): Falls: Risk Assessment National Quality Strategy Domain: Patient Safety

Study Endpoint Considerations: Final PRO Guidance and Beyond

Copyright American Psychological Association

Residual Functional Capacity Questionnaire MULTIPLE SCLEROSIS

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Efficiency

CDISC SHARE. CDISC Shared Health and Research Electronic Library Pilot Report. Date: 19 January 2010 Version: 1.0 CDISC, 2010

4. Pertinent physical findings including: a. Results of tests performed on patient, including dates and specific findings:

Breast Cancer TAUG Overview and Implementation

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process

Quality ID #110 (NQF 0041): Preventive Care and Screening: Influenza Immunization National Quality Strategy Domain: Community/Population Health

Quality ID #119 (NQF 0062): Diabetes: Medical Attention for Nephropathy National Quality Strategy Domain: Effective Clinical Care

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process-High Priority

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

DENOMINATOR: All female patients aged 65 years and older with a visit during the measurement period

CLASSIFICATION AND TREATMENT PLANS

DENOMINATOR: All patients 18 and older prescribed opiates for longer than six weeks duration

Modular Program Report

Quality ID #155 (NQF: 0101): Falls: Plan of Care National Quality Strategy Domain: Communication and Care Coordination

Dementia Friendly Communities Recognition Process. Karishma Chandaria Dementia Friendly Communities Programme Manager

Transcription:

Barnes Akathisia Rating Scale () Questionnaire Supplement to the Study Data Tabulation Model Implementation Guide for Human Clinical Trials Prepared by CDISC Questionnaire Sub-team Notes to Readers This supplement is intended to be used with other CDISC User Guides for specific Therapeutic/Disease Areas and follows the CDISC Study Data Tabulation Model Implementation Guide for Human Clinical trials. Revision History Date Version Summary of Changes 2013-05-15 1.0 Barnes Akathisia Rating Scale () Draft 2013 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 1

1 Introduction This document describes the CDISC implementation of the Barnes Akathisia Rating Scale () questionnaire, a standard questionnaire that is typically used in clinical trials to provide an assessment of akathisia. The questionnaire preceded the CDISC CDASH CRF standards and based on its public domain status cannot be modified to CDASH standards. The representation of data collected for this questionnaire is based on the Study Data Tabulation Model Implementation Guide (SDTMIG) QS domain model, which can be found at the CDISC website at: (http://www.cdisc.org/sdtm). These specific implementation details for this questionnaire are meant to be used in conjunction with the SDTMIG. All questionnaire documentation can be found on the CDISC web site at: (http://www.cdisc.org/content2909). The CDISC Intellectual Property Policy can be found on the CDISC web site at: (http://www.cdisc.org/bylaws-and-policies). 1.1 Representations and Warranties, Limitations of Liability, and Disclaimers This document is a supplement to the Study Data Tabulation Model Implementation Guide for Human Clinical Trials and is covered under Appendix F of that document, which describes representations, warranties, limitations of liability, and disclaimers. Please see Appendix F of the SDTMIG for a complete version of this material. 2 Copyright Status This instrument is in the public domain. CDISC has included the Barnes Akathisia Rating Scale () as part of CDISC Data Standards. Hence, CDISC developed QSTESTCD and QSTEST for each question based on the actual question text on the questionnaire. There may be many versions of this questionnaire in the public domain. CDISC has chosen to use this version as the data standard. The CDISC documentation of this instrument consists of: (1) controlled terminology, (2) standard database structure with examples, and (3) case report forms annotated with the CDISC SDTMIG submission values. Note: CDISC controlled terminology is maintained by NCI EVS. The most recent version should be accessed through the CDISC website. (http://www.cdisc.org/terminology) CDISC has developed this documentation at no cost to users of the instrument. The reference for this questionnaire is: Barnes Akathisia Rating Scale () (Barnes TR: A Rating Scale for Drug-Induced Akathisia. British Journal of Psychiatry 154:672-676, 1989). 2013 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 2

3 The QS Domain Model 3.1 Assumptions for Questionnaire Domain Model All assumptions and business rules described in the SDTMIG QS domain are applicable to this supplement. Additional assumptions specific to the Barnes Akathisia Rating Scale are listed below. Barnes Akathisia Rating Scale (): is a multiple-choice questionnaire that clinicians may use to provide an assessment of akathisia. Akathisia is defined by www.dictionary.com as a state of motor restlessness, sometimes produced by neuroleptic medication that ranges from a feeling of inner distress to an inability to sit still. 1. The investigator is instructed to observe the subject while standing and while sitting, at least two minutes each. There are four areas where the subject is to be evaluated, one of these is objective, two are subjective, and the final is a global assessment. 2. Six of the textual assessments, one of the objective and five of the global, are greater than the 200 characters limit currently mandated by the FDA, and hence, CDISC. To accommodate these in QSORRES the QS subteam has decided to shorten the responses to accommodate the character limit. The original and shortened values are summarized in Section 5. 3. Because the four minutes that the investigator must observe the subject is a minimum observation period, and not the actual evaluation interval, coupled with the fact that the investigator may use additional observations from other situations, there is not a value for the evaluation interval (QSEVLINT). 4. For, the evaluator is usually defined as INVESTIGATOR. Additional identifying information to further distinguish the rater in QSEVAL should be stored in QSEVALID. An example is rater initials. 5. Terminology: a. QSCAT, QSTESTCD and QSTEST are approved CDISC controlled terminology. b. A full list of value sets for qualifier, timing, result and unit fields is provided in Section 4: SDTM Mapping Strategy. 2013 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 3

3.2 Example for Barnes Akathisia Rating Scale () QS Domain Model The example below shows the terminology used to implement the questionnaire in the QS domain. This example shows the data for four subjects collected at one visit for a questionnaire. The example uses CDISC controlled terminology for QSTESTCD, QSTEST, and QSCAT. Rows 1-16 represent the questions from the form. All original results are represented with preferred terminology in QSORRES. This result is then standardized into its numeric equivalent in the character field of QSSTRESC, and this value is then transferred to the QSSTRESN field, in numeric format. Rows 4, 8, 12, 13, and 16 had QSORRES values that needed to be shortened in order to meet the 200 character SAS transport file V5 restriction. QS.XPT ROW STUDYID DOMAIN USUBJID QSSEQ QSTESTCD QSTEST QSCAT QSORRES QSSTRESC 1 STUDY001 QS 001-001 1 0101 01-Objective 2 STUDY001 QS 001-001 2 0102 3 STUDY001 QS 001-001 3 0103 Awareness Distress NORMAL, OCCASIONAL FIDGETY MOVEMENTS OF THE LIMBS NON-SPECIFIC SENSE OF INNER RESTLESSNESS 1 MODERATE 2 0 4 STUDY001 QS 001-001 4 0104 01-Global Clinical Assessment MILD AKATHISIA. AWARE OF RESTLESSNESS IN THE LEGS AND/OR INNER RESTLESSNESS WORSE WHEN REQUIRED TO STAND STILL. FIDGETY MOVEMENTS, BUT RESTLESS MOVEMENTS NOT NECESSARILY OBSERVED. LITTLE/NO DISTRESS. 2 5 STUDY001 QS 001-002 1 0101 01-Objective PATIENT IS CONSTANTLY ENGAGED IN CHARACTERISTIC RESTLESS MOVEMENTS, AND/OR HAS THE INABILITY TO REMAIN SEATED OR STANDING WITHOUT WALKING OR PACING, DURING THE TIME OBSERVED 3 6 STUDY001 QS 001-002 2 0102 7 STUDY001 QS 001-002 3 0103 Awareness Distress AWARENESS OF INTENSE COMPULSION TO MOVE MOST OF THE TIME AND/OR REPORTS STRONG DESIRE TO WALK OR PACE MOST OF THE TIME MODERATE 2 3 2013 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 4

ROW STUDYID DOMAIN USUBJID QSSEQ QSTESTCD QSTEST QSCAT QSORRES QSSTRESC 8 STUDY001 QS 001-002 4 0104 01-Global Clinical Assessment SEVERE AKATHISIA. A STRONG COMPULSION TO PACE UP AND DOWN MOST OF THE TIME. UNABLE TO SIT OR LIE DOWN FOR MORE THAN A FEW MINUTES. CONSTANT RESTLESSNESS ASSOCIATED WITH INTENSE DISTRESS AND INSOMNIA. 5 9 STUDY001 QS 001-003 1 0101 01-Objective OBSERVED PHENOMENA, AS DESCRIBED IN (1) ABOVE, WHICH ARE PRESENT FOR AT LEAST HALF THE OBSERVATION PERIOD 2 10 STUDY001 QS 001-003 2 0102 Awareness THE PATIENT IS AWARE OF AN INABILITY TO KEEP THE LEGS STILL, OR A DESIRE TO MOVE THE LEGS, AND/OR COMPLAINS OF INNER RESTLESSNESS AGGRAVATED SPECIFICALLY BY BEING REQUIRED TO STAND STILL 2 11 STUDY001 QS 001-003 3 0103 Distress MILD 1 12 STUDY001 QS 001-003 4 0104 01-Global Clinical Assessment MODERATE AKATHISIA. AWAREOF RESTLESSNESS AS DESCRIBED FOR MILD AKATHISIA ABOVE, COMBINED WITH CHARACTERISTIC RESTLESS MOVEMENTS SUCH AS ROCKING FROM FOOT TO FOOT WHEN STANDING. CONDITION DISTRESSING 3 13 STUDY001 QS 001-004 1 0101 01-Objective RESTLESS MOVEMENTS: SHUFFLING OR TRAMPING MOVEMENTS. SWINGING OF ONE LEG WHILE SITTING, AND/OR ROCKING FROM FOOT TO FOOT OR WALKING ON THE SPOT WHEN STANDING, PRESENT FOR LESS THAN HALF THE TIME 1 14 STUDY001 QS 001-004 2 0102 15 STUDY001 QS 001-004 3 0103 Awareness Distress NON-SPECIFIC SENSE OF INNER RESTLESSNESS 1 NO DISTRESS 0 16 STUDY001 QS 001-004 4 0104 01-Global Clinical Assessment ABSENT. NO EVIDENCE OF AWARENESS OF RESTLESSNESS. MOVEMENTS OF AKATHISIA IN THE ABSENCE OF INNER RESTLESSNESS OR COMPULSIVE DESIRE TO MOVE THE LEGS SHOULD BE CLASSIFIED AS PSEUDOAKATHISIA 0 2013 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 5

ROW QSSTRESN QSBLFL QSEVAL VISITNUM QSDTC 1 0 Y INVESTIGATOR 1 2013-01-08 2 1 Y INVESTIGATOR 1 2013-01-08 3 2 Y INVESTIGATOR 1 2013-01-08 4 2 Y INVESTIGATOR 1 2013-01-08 5 3 Y INVESTIGATOR 1 2013-01-08 6 3 Y INVESTIGATOR 1 2013-01-08 7 2 Y INVESTIGATOR 1 2013-01-08 8 5 Y INVESTIGATOR 1 2013-01-08 9 2 Y INVESTIGATOR 1 2013-01-10 10 2 Y INVESTIGATOR 1 2013-01-10 11 1 Y INVESTIGATOR 1 2013-01-10 2013 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 6

ROW QSSTRESN QSBLFL QSEVAL VISITNUM QSDTC 12 3 Y INVESTIGATOR 1 2013-01-10 13 1 Y INVESTIGATOR 1 2013-01-10 14 1 Y INVESTIGATOR 1 2013-01-10 15 0 Y INVESTIGATOR 1 2013-01-10 16 0 Y INVESTIGATOR 1 2013-01-10 2013 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 7

CDISC SDTM Questionnaire Supplement (Version 0.1) 4 SDTM Mapping Strategy specific mapping strategy: This section is used for reference with the annotated CRF for further details on the CRF data capture and to understand the alignment of the questionnaire to the SDTM QS domain. It also provides guidance on how the result variables (QSORRES, QSSTRESC, and QSSTRESN) should be populated for the questionnaire. QSTESTCD=0101 QSTEST= 01-Objective QSORRES QSSTRESC QSSTRESN NORMAL, OCCASIONAL FIDGETY MOVEMENTS OF THE LIMBS 0 0 RESTLESS MOVEMENTS: SHUFFLING OR TRAMPING MOVEMENTS. SWINGING OF ONE LEG WHILE SITTING, AND/OR ROCKING FROM FOOT TO FOOT OR WALKING ON THE SPOT WHEN STANDING, PRESENT FOR LESS THAN HALF THE TIME OBSERVED PHENOMENA, AS DESCRIBED IN (1) ABOVE, WHICH ARE PRESENT FOR AT LEAST HALF THE OBSERVATION PERIOD PATIENT IS CONSTANTLY ENGAGED IN CHARACTERISTIC RESTLESS MOVEMENTS, AND/OR HAS THE INABILITY TO REMAIN SEATED OR STANDING WITHOUT WALKING OR PACING, DURING THE TIME OBSERVED 1 1 2 2 3 3 QSTESTCD=0102 QSTEST= Awareness QSORRES QSSTRESC QSSTRESN ABSENCE OF INNER RESTLESSNESS 0 0 NON-SPECIFIC SENSE OF INNER RESTLESSNESS 1 1 THE PATIENT IS AWARE OF AN INABILITY TO KEEP THE LEGS STILL, OR A DESIRE TO MOVE THE LEGS, AND/OR COMPLAINS OF INNER RESTLESSNESS AGGRAVATED SPECIFICALLY BY BEING REQUIRED TO STAND STILL AWARENESS OF INTENSE COMPULSION TO MOVE MOST OF THE TIME AND/OR REPORTS STRONG DESIRE TO WALK OR PACE MOST OF THE TIME 2 2 3 3 2013 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 8

CDISC SDTM Questionnaire Supplement (Version 0.1) QSTESTCD=0103 QSTEST= Distress QSORRES QSSTRESC QSSTRESN NO DISTRESS 0 0 MILD 1 1 MODERATE 2 2 SEVERE 3 3 QSTESTCD=0104 QSTEST= 01-Global Clinical Assessment QSORRES QSSTRESC QSSTRESN ABSENT. NO EVIDENCE OF AWARENESS OF RESTLESSNESS. MOVEMENTS OF AKATHISIA IN THE ABSENCE OF INNER RESTLESSNESS OR COMPULSIVE DESIRE TO MOVE THE LEGS SHOULD BE CLASSIFIED AS PSEUDOAKATHISIA 0 0 QUESTIONABLE. NON-SPECIFIC INNER TENSION AND FIDGETY MOVEMENTS 1 1 MILD AKATHISIA. AWARE OF RESTLESSNESS IN THE LEGS AND/OR INNER RESTLESSNESS WORSE WHEN REQUIRED TO STAND STILL. FIDGETY MOVEMENTS, BUT RESTLESS MOVEMENTS NOT NECESSARILY OBSERVED. LITTLE/NO DISTRESS. MODERATE AKATHISIA. AWAREOF RESTLESSNESS AS DESCRIBED FOR MILD AKATHISIA ABOVE, COMBINED WITH CHARACTERISTIC RESTLESS MOVEMENTS SUCH AS ROCKING FROM FOOT TO FOOT WHEN STANDING. CONDITION DISTRESSING MARKED AKATHISIA. RESTLESSNESS INCLUDES A COMPULSIVE DESIRE TO WALK OR PACE. HOWEVER, THE PATIENT IS ABLE TO REMAIN SEATED FOR AT LEAST FIVE MINUTES. THE CONDITION IS OBVIOUSLY DISTRESSING. SEVERE AKATHISIA. A STRONG COMPULSION TO PACE UP AND DOWN MOST OF THE TIME. UNABLE TO SIT OR LIE DOWN FOR MORE THAN A FEW MINUTES. CONSTANT RESTLESSNESS ASSOCIATED WITH INTENSE DISTRESS AND INSOMNIA. 2 2 3 3 4 4 5 5 2013 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 9

CDISC SDTM Questionnaire Supplement (Version 0.1) 5 Original and QSORRES Comparison 01-Objective (Original) NORMAL, OCCASIONAL FIDGETY MOVEMENTS OF THE LIMBS PRESENCE OF CHARACTERISTIC RESTLESS MOVEMENTS: SHUFFLING OR TRAMPING MOVEMENTS OF THE LEGS/FEET, OR SWINGING OF ONE LEG WHILE SITTING, AND/OR ROCKING FROM FOOT TO FOOT OR WALKING ON THE SPOT WHEN STANDING, BUT MOVEMENTS PRESENT FOR LESS THAN HALF THE TIME OBSERVED QSORRES Value NORMAL, OCCASIONAL FIDGETY MOVEMENTS OF THE LIMBS RESTLESS MOVEMENTS: SHUFFLING OR TRAMPING MOVEMENTS. SWINGING OF ONE LEG WHILE SITTING, AND/OR ROCKING FROM FOOT TO FOOT OR WALKING ON THE SPOT WHEN STANDING, PRESENT FOR LESS THAN HALF THE TIME OBSERVED PHENOMENA, AS DESCRIBED IN (1) ABOVE, WHICH ARE PRESENT FOR AT LEAST HALF THE OBSERVATION PERIOD PATIENT IS CONSTANTLY ENGAGED IN CHARACTERISTIC RESTLESS MOVEMENTS, AND/OR HAS THE INABILITY TO REMAIN SEATED OR STANDING WITHOUT WALKING OR PACING, DURING THE TIME OBSERVED Awareness (Original) ABSENCE OF INNER RESTLESSNESS NON-SPECIFIC SENSE OF INNER RESTLESSNESS THE PATIENT IS AWARE OF AN INABILITY TO KEEP THE LEGS STILL, OR A DESIRE TO MOVE THE LEGS, AND/OR COMPLAINS OF INNER RESTLESSNESS AGGRAVATED SPECIFICALLY BY BEING REQUIRED TO STAND STILL AWARENESS OF INTENSE COMPULSION TO MOVE MOST OF THE TIME AND/OR REPORTS STRONG DESIRE TO WALK OR PACE MOST OF THE TIME Distress (Original) NO DISTRESS MILD MODERATE SEVERE OBSERVED PHENOMENA, AS DESCRIBED IN (1) ABOVE, WHICH ARE PRESENT FOR AT LEAST HALF THE OBSERVATION PERIOD PATIENT IS CONSTANTLY ENGAGED IN CHARACTERISTIC RESTLESS MOVEMENTS, AND/OR HAS THE INABILITY TO REMAIN SEATED OR STANDING WITHOUT WALKING OR PACING, DURING THE TIME OBSERVED QSORRES Value ABSENCE OF INNER RESTLESSNESS NON-SPECIFIC SENSE OF INNER RESTLESSNESS THE PATIENT IS AWARE OF AN INABILITY TO KEEP THE LEGS STILL, OR A DESIRE TO MOVE THE LEGS, AND/OR COMPLAINS OF INNER RESTLESSNESS AGGRAVATED SPECIFICALLY BY BEING REQUIRED TO STAND STILL AWARENESS OF INTENSE COMPULSION TO MOVE MOST OF THE TIME AND/OR REPORTS STRONG DESIRE TO WALK OR PACE MOST OF THE TIME QSORRES Value NO DISTRESS MILD MODERATE SEVERE 2013 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 10

CDISC SDTM Questionnaire Supplement (Version 0.1) 01-Global Clinical Assessment ABSENT. NO EVIDENCE OF AWARENESS OF RESTLESSNESS. OBSERVATION OF CHARACTERISTIC MOVEMENTS OF AKATHISIA IN THE ABSENCE OF A SUBJECTIVE REPORT OF INNER RESTLESSNESS OR COMPULSIVE DESIRE TO MOVE THE LEGS SHOULD BE CLASSIFIED AS PSEUDOAKATHISIA QSORRES Value ABSENT. NO EVIDENCE OF AWARENESS OF RESTLESSNESS. MOVEMENTS OF AKATHISIA IN THE ABSENCE OF INNER RESTLESSNESS OR COMPULSIVE DESIRE TO MOVE THE LEGS SHOULD BE CLASSIFIED AS PSEUDOAKATHISIA QUESTIONABLE. NON-SPECIFIC INNER TENSION AND FIDGETY MOVEMENTS MILD AKATHISIA. AWARENESS OF RESTLESSNESS IN THE LEGS AND/OR INNER RESTLESSNESS WORSE WHEN REQUIRED TO STAND STILL. FIDGETY MOVEMENTS PRESENT, BUT CHARACTERISTIC RESTLESS MOVEMENTS OF AKATHISIA NOT NECESSARILY OBSERVED. CONDITION CAUSES LITTLE OR NO DISTRESS. QUESTIONABLE. NON-SPECIFIC INNER TENSION AND FIDGETY MOVEMENTS MILD AKATHISIA. AWARE OF RESTLESSNESS IN THE LEGS AND/OR INNER RESTLESSNESS WORSE WHEN REQUIRED TO STAND STILL. FIDGETY MOVEMENTS, BUT RESTLESS MOVEMENTS NOT NECESSARILY OBSERVED. LITTLE/NO DISTRESS. MODERATE AKATHISIA. AWARENESS OF RESTLESSNESS AS DESCRIBED FOR MILD AKATHISIA ABOVE, COMBINED WITH CHARACTERISTIC RESTLESS MOVEMENTS SUCH AS ROCKING FROM FOOT TO FOOT WHEN STANDING. PATIENT FINDS THE CONDITION DISTRESSING MARKED AKATHISIA. SUBJECTIVE EXPERIENCE OF RESTLESSNESS INCLUDES A COMPULSIVE DESIRE TO WALK OR PACE. HOWEVER, THE PATIENT IS ABLE TO REMAIN SEATED FOR AT LEAST FIVE MINUTES. THE CONDITION IS OBVIOUSLY DISTRESSING. SEVERE AKATHISIA. THE PATIENT REPORTS A STRONG COMPULSION TO PACE UP AND DOWN MOST OF THE TIME. UNABLE TO SIT OR LIE DOWN FOR MORE THAN A FEW MINUTES. CONSTANT RESTLESSNESS WHICH IS ASSOCIATED WITH INTENSE DISTRESS AND INSOMNIA. MODERATE AKATHISIA. AWAREOF RESTLESSNESS AS DESCRIBED FOR MILD AKATHISIA ABOVE, COMBINED WITH CHARACTERISTIC RESTLESS MOVEMENTS SUCH AS ROCKING FROM FOOT TO FOOT WHEN STANDING. CONDITION DISTRESSING MARKED AKATHISIA. RESTLESSNESS INCLUDES A COMPULSIVE DESIRE TO WALK OR PACE. HOWEVER, THE PATIENT IS ABLE TO REMAIN SEATED FOR AT LEAST FIVE MINUTES. THE CONDITION IS OBVIOUSLY DISTRESSING. SEVERE AKATHISIA. A STRONG COMPULSION TO PACE UP AND DOWN MOST OF THE TIME. UNABLE TO SIT OR LIE DOWN FOR MORE THAN A FEW MINUTES. CONSTANT RESTLESSNESS ASSOCIATED WITH INTENSE DISTRESS AND INSOMNIA. End of Document 2013 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 11